Heterozygous Familial Hypercholesterolemia

Explore clinical trials studying Heterozygous Familial Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

26 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Heterozygous Familial Hypercholesterolemia trial results

Completed

NCT01968980

Conditions: Heterozygous Familial Hypercholesterolemia
Locations: IMD Medical Group Los Angeles, California, United States

Hartford Hospital, JB704 Hartford, Connecticut, United States

Best Quality Research, Inc. Hialeah, Florida, United States

Medical Research Center Miami, Florida, United States

View all 88 locations

Completed

NCT00706849

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +17 more
Locations: La Jolla, California, United States

Los Angeles, California, United States

Mission Viejo, California, United States

Newport Beach, California, United States

View all 48 locations

Completed

NCT01709500

Conditions: Heterozygous Familial Hypercholesterolemia
Locations: Hradec Králové, Czechia

Prague, Czechia

Trutnov, Czechia

Vyškov, Czechia

View all 24 locations

Completed

NCT01515241

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Montreal Heart Institute Montreal, Quebec, Canada

Completed

NCT00171236

Active, Not Recruiting

NCT06958315

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +4 more
Locations: Novartis Investigative Site Cadiz, Andalusia, Spain

Novartis Investigative Site Granada, Andalusia, Spain

Novartis Investigative Site Huelva, Andalusia, Spain

Novartis Investigative Site Jaén, Andalusia, Spain

View all 19 locations